| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR SER TR | 600,000 | 35,514,000 | 8.55% | Put | |
| 2 | SHIRE PLC | 100,000 | 17,038,000 | 4.10% | ||
| 3 | ABBOTT LABS | 400,000 | 15,364,000 | 3.70% | ||
| 4 | ALEXION PHARMACEUTIC | 115,000 | 14,070,000 | 3.39% | ||
| 5 | ZIMMER BIOMET HLDGS INC | 130,000 | 13,416,000 | 3.23% | ||
| 6 | MERCK & CO INC | 225,000 | 13,246,000 | 3.19% | ||
| 7 | CELGENE CORP | 110,000 | 12,733,000 | 3.06% | ||
| 8 | DBV TECHNOLOGIES | 325,000 | 11,417,000 | 2.75% | ||
| 9 | SAGE THERAPEUTICS | 200,000 | 10,212,000 | 2.46% | ||
| 10 | NUVASIVE INC COM | 150,000 | 10,104,000 | 2.43% | ||
| 11 | ACADIA PHARMACEUTICALS INC COM | 350,000 | 10,094,000 | 2.43% | Call | |
| 12 | CLOVIS ONCOLOGY INC | 220,000 | 9,772,000 | 2.35% | ||
| 13 | BOSTON SCIENTIFIC CORP | 450,000 | 9,734,000 | 2.34% | ||
| 14 | BRISTOL MYERS SQUIBB CO | 150,000 | 8,766,000 | 2.11% | Call | |
| 15 | AVEXIS INC COM | 175,000 | 8,353,000 | 2.01% | ||
| 16 | SPECTRANETICS CORP | 335,000 | 8,208,000 | 1.98% | ||
| 17 | SEATTLE GENETICS INC | 150,000 | 7,916,000 | 1.91% | ||
| 18 | ABBOTT LABS | 200,000 | 7,682,000 | 1.85% | Call | |
| 19 | INTERCEPT PHARMACEUTICAL | 70,000 | 7,606,000 | 1.83% | ||
| 20 | NEURODERM LTD | 330,000 | 7,326,000 | 1.76% | ||
| 21 | BIOCRYST PHARMACEUTICALS | 1,150,000 | 7,280,000 | 1.75% | ||
| 22 | GLAUKOS CORP | 200,000 | 6,860,000 | 1.65% | ||
| 23 | Lion Biotechnologies | 975,000 | 6,776,000 | 1.63% | ||
| 24 | MALLINCKRODT PUB LTD CO SHS | 135,000 | 6,726,000 | 1.62% | ||
| 25 | AERIE PHARMACEUTICALS INC | 175,000 | 6,624,000 | 1.59% | ||
| 26 | NEVRO CORP | 90,000 | 6,539,000 | 1.57% | ||
| 27 | BOSTON SCIENTIFIC CORP | 300,000 | 6,489,000 | 1.56% | Call | |
| 28 | IMMUNOMEDICS INC | 1,700,000 | 6,239,000 | 1.50% | ||
| 29 | PUMA BIOTECHNOLOGY | 200,000 | 6,140,000 | 1.48% | Call | |
| 30 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 575,000 | 5,974,000 | 1.44% | ||
| 31 | BRISTOL MYERS SQUIBB CO | 100,000 | 5,844,000 | 1.41% | ||
| 32 | AGIOS PHARMACEUTICALS INC | 140,000 | 5,842,000 | 1.41% | ||
| 33 | PERRIGO CO PLC | 70,000 | 5,826,000 | 1.40% | ||
| 34 | EPIZYME INC COM | 475,000 | 5,748,000 | 1.38% | ||
| 35 | NANOSTRING TECHNOLOGIES INC | 250,000 | 5,575,000 | 1.34% | ||
| 36 | SAREPTA THERAPEUTICS INC | 200,000 | 5,486,000 | 1.32% | Call | |
| 37 | CURRENCYSHARES SWISS | 46,400 | 4,349,000 | 1.05% | ||
| 38 | BIOGEN INC | 15,000 | 4,254,000 | 1.02% | ||
| 39 | ENDO INTL | 250,000 | 4,118,000 | 0.99% | ||
| 40 | Foamix Pharmaceuticals Ltd. | 365,000 | 4,052,000 | 0.98% | ||
| 41 | Wright Medical Group NV | 175,000 | 4,022,000 | 0.97% | ||
| 42 | SPARK THERAPEUTICS INC | 80,000 | 3,992,000 | 0.96% | ||
| 43 | ENTELLUS MEDICAL INC | 200,000 | 3,794,000 | 0.91% | ||
| 44 | QIAGEN NV | 135,000 | 3,783,000 | 0.91% | ||
| 45 | Aquinox Pharmaceuticals Inc | 225,000 | 3,715,000 | 0.89% | ||
| 46 | IRHYTHM TECHNOLOGIES INC COM ADDED | 115,182 | 3,455,000 | 0.83% | ||
| 47 | ACLARIS THERAPEUTICS INC COM | 120,000 | 3,257,000 | 0.78% | ||
| 48 | ACADIA PHARMACEUTICALS INC COM | 100,000 | 2,884,000 | 0.69% | ||
| 49 | IRIDEX CORP COM | 200,000 | 2,812,000 | 0.68% | ||
| 50 | ZOGENIX INC | 225,000 | 2,734,000 | 0.66% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-17-000789, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
